Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-22-021950
Filing Date
2022-08-09
Accepted
2022-08-09 16:18:15
Documents
114
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A fhtx-20211231.htm   iXBRL 10-K/A 2069664
2 EX-23.1 ex231deloitte-form10xk_aco.htm EX-23.1 2281
3 EX-31.1 fhtx-20211231xamendedex311.htm EX-31.1 10581
4 EX-31.2 fhtx-20211231xamendedex312.htm EX-31.2 10560
5 EX-32.1 fhtx-20211231xamendedex321.htm EX-32.1 4907
6 EX-32.2 fhtx-20211231xamendedex322.htm EX-32.2 4868
12 GRAPHIC fhtx-20211231_g1.jpg GRAPHIC 239764
13 GRAPHIC fhtx-20211231_g10.jpg GRAPHIC 41976
14 GRAPHIC fhtx-20211231_g11.jpg GRAPHIC 40666
15 GRAPHIC fhtx-20211231_g12.jpg GRAPHIC 33120
16 GRAPHIC fhtx-20211231_g13.jpg GRAPHIC 35667
17 GRAPHIC fhtx-20211231_g14.jpg GRAPHIC 38720
18 GRAPHIC fhtx-20211231_g15.jpg GRAPHIC 52853
19 GRAPHIC fhtx-20211231_g16.jpg GRAPHIC 46275
20 GRAPHIC fhtx-20211231_g17.jpg GRAPHIC 102084
21 GRAPHIC fhtx-20211231_g18.jpg GRAPHIC 100981
22 GRAPHIC fhtx-20211231_g19.jpg GRAPHIC 64389
23 GRAPHIC fhtx-20211231_g2.jpg GRAPHIC 20617
24 GRAPHIC fhtx-20211231_g20.jpg GRAPHIC 64904
25 GRAPHIC fhtx-20211231_g21.jpg GRAPHIC 119524
26 GRAPHIC fhtx-20211231_g22.jpg GRAPHIC 74448
27 GRAPHIC fhtx-20211231_g23.jpg GRAPHIC 107457
28 GRAPHIC fhtx-20211231_g24.jpg GRAPHIC 139498
29 GRAPHIC fhtx-20211231_g25.jpg GRAPHIC 86711
30 GRAPHIC fhtx-20211231_g26.jpg GRAPHIC 96414
31 GRAPHIC fhtx-20211231_g27.jpg GRAPHIC 103363
32 GRAPHIC fhtx-20211231_g28.jpg GRAPHIC 116204
33 GRAPHIC fhtx-20211231_g29.jpg GRAPHIC 64413
34 GRAPHIC fhtx-20211231_g3.jpg GRAPHIC 30699
35 GRAPHIC fhtx-20211231_g30.jpg GRAPHIC 41972
36 GRAPHIC fhtx-20211231_g31.jpg GRAPHIC 44498
37 GRAPHIC fhtx-20211231_g32.jpg GRAPHIC 42693
38 GRAPHIC fhtx-20211231_g33.jpg GRAPHIC 119644
39 GRAPHIC fhtx-20211231_g34.jpg GRAPHIC 82912
40 GRAPHIC fhtx-20211231_g35.jpg GRAPHIC 78264
41 GRAPHIC fhtx-20211231_g36.jpg GRAPHIC 105125
42 GRAPHIC fhtx-20211231_g37.jpg GRAPHIC 45443
43 GRAPHIC fhtx-20211231_g4.jpg GRAPHIC 34387
44 GRAPHIC fhtx-20211231_g5.jpg GRAPHIC 27241
45 GRAPHIC fhtx-20211231_g6.jpg GRAPHIC 9130
46 GRAPHIC fhtx-20211231_g7.jpg GRAPHIC 101274
47 GRAPHIC fhtx-20211231_g8.jpg GRAPHIC 121693
48 GRAPHIC fhtx-20211231_g9.jpg GRAPHIC 41012
  Complete submission text file 0001628280-22-021950.txt   14120565

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20211231.xsd EX-101.SCH 47952
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20211231_cal.xml EX-101.CAL 83433
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20211231_def.xml EX-101.DEF 230323
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20211231_lab.xml EX-101.LAB 659008
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20211231_pre.xml EX-101.PRE 430387
108 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20211231_htm.xml XML 1026487
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39634 | Film No.: 221148598
SIC: 2834 Pharmaceutical Preparations